96 related articles for article (PubMed ID: 25518512)
1. [Role of eosinophil granulocytes in the occurrence of restenosis in patients after coronary stenting with drug-eluting stents].
Gabbasov ZA; Kozlov SG; Imaeva AÉ; Saburova OS; Masenko VP
Ter Arkh; 2014; 86(9):90-6. PubMed ID: 25518512
[TBL] [Abstract][Full Text] [Related]
2. [Eosinophilic cation protein and development of restenosis of drug covered stents].
Gabbasov ZA; Kozlov SG; Saburova OS; Imaeva AÉ; Bosykh EG; Liakishev AA; Zykov KA; Masenko VP
Kardiologiia; 2011; 51(6):49-54. PubMed ID: 21878071
[TBL] [Abstract][Full Text] [Related]
3. In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein.
Gabbasov ZA; Kozlov SG; Imaeva AE; Saburova OS; Zykov KA; Masenko VP; Smirnov VN
Can J Physiol Pharmacol; 2011 Jun; 89(6):413-8. PubMed ID: 21751895
[TBL] [Abstract][Full Text] [Related]
4. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents.
Niccoli G; Schiavino D; Belloni F; Ferrante G; La Torre G; Conte M; Cosentino N; Montone RA; Sabato V; Burzotta F; Trani C; Leone AM; Porto I; Pieroni M; Patriarca G; Crea F
Eur Heart J; 2009 Jun; 30(11):1340-7. PubMed ID: 19383735
[TBL] [Abstract][Full Text] [Related]
5. Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein.
Niccoli G; Calvieri C; Minelli S; Copponi G; Montone RA; Imaeva A; Roberto M; Cosentino N; Crea F
Atherosclerosis; 2014 Dec; 237(2):816-20. PubMed ID: 25463127
[TBL] [Abstract][Full Text] [Related]
6. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
[TBL] [Abstract][Full Text] [Related]
7. Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents.
Gabbasov ZA; Kozlov SG; Lyakishev AA; Saburova OS; Smirnov VA; Smirnov VN
Can J Physiol Pharmacol; 2009 Feb; 87(2):130-6. PubMed ID: 19234576
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.
Kim JY; Ko YG; Shim CY; Park S; Hwang KC; Choi D; Jang Y; Chung N; Shim WH; Cho SY
Am J Cardiol; 2005 Nov; 96(10):1384-8. PubMed ID: 16275183
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.
Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R
Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473
[TBL] [Abstract][Full Text] [Related]
11. [Results of implantation of drug-eluting stents in extensive lesion of the coronary bed according to angiographic and intravascular ultrasound findings].
Cherkavskaia OV; Savchenko AP; Rudenko BA; Merkulov EV
Vestn Rentgenol Radiol; 2012; (2):14-9. PubMed ID: 22730754
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
[TBL] [Abstract][Full Text] [Related]
13. The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting.
Hajizadeh R; Ghaffari S; Separham A; Shokouhi B; Kavandi H; Pourafkari L; Nader ND
Rom J Intern Med; 2017 Dec; 55(4):229-236. PubMed ID: 28672766
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
17. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
[TBL] [Abstract][Full Text] [Related]
20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
